The largest database of trusted experimental protocols

Md gastroview

Manufactured by Mallinckrodt

MD-Gastroview is a non-ionic iodinated contrast agent formulation used for radiographic examination of the gastrointestinal tract. It is designed to provide visualization and evaluation of the esophagus, stomach, and intestines during diagnostic procedures.

Automatically generated - may contain errors

2 protocols using md gastroview

1

Imaging Colitis Inflammation with PET-CT

Check if the same lab product or an alternative is used in the 5 most similar protocols
PET-CT scanning was performed 48 h after colitis induction in selected experiments as described previously (24 (link)) with minor modifications. Briefly, fasted (for 6 h) mice were anesthetized with isoflurane and received 200 µCi [18F]FDG by intraperitoneal (i.p.) injection. One hour later, these mice received 200 µl MD-Gastroview (Mallinckrodt Inc., MO) rectally via a 3.5 French (F) catheter immediately before scan initiation. Computed tomography (CT) scanning was performed for 10 min followed by PET scanning for 20 min using the Inveon PET-CT multimodality system (Siemens). Mice were kept sedated during the scanning process by constant isoflurane inhalation. The images were recorded, and FDG standardized uptake values (SUVs) were analyzed blindly using Inveon Research Workplace software. The MD-Gastroview appears as radiopaque in the CT image, thus highlighting the colon clearly. A region of interest (ROI) comprising the colon was extracted from the CT scan and transferred to the space of the PET scan. Tissues/organs (such as the bladder) other than the colon were excluded from the measurements, and the averages of SUVs of the remaining voxels were calculated to represent the severity of the inflammation.
+ Open protocol
+ Expand
2

Optimizing Bowel Preparation for CTC

Check if the same lab product or an alternative is used in the 5 most similar protocols
Starting the day before the scheduled CTC examination, patients were restricted to a clear liquid diet and received two 5-mg bisacodyl tablets, which were taken before 11:00 AM. Three to six hours after the bisacodyl tablets, patients ingested the different cathartic agents. The five regimens were as follows:
The evening before CTC all patient groups were also given 250 mL of (2%) barium sulfate (Readi-Cat 2; E-Z- EM, Lake Success, NY) to tag residual solid stool and 60 mL of sodium diatrizoate/diatrizoate meglumine (MD-Gastroview; Mallinckrodt, Hazelwood, MO) to tag residual fluid and provide supplementary tagging. This oral contrast regimen was repeated on the morning of the examination for the double-dose NaP group only.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!